PMC:7243778 / 14674-14955 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"339","span":{"begin":104,"end":108},"obj":"Gene"},{"id":"340","span":{"begin":263,"end":267},"obj":"Gene"},{"id":"341","span":{"begin":226,"end":227},"obj":"Gene"},{"id":"342","span":{"begin":45,"end":60},"obj":"Species"},{"id":"343","span":{"begin":19,"end":24},"obj":"Species"}],"attributes":[{"id":"A339","pred":"tao:has_database_id","subj":"339","obj":"Gene:59272"},{"id":"A340","pred":"tao:has_database_id","subj":"340","obj":"Gene:59272"},{"id":"A341","pred":"tao:has_database_id","subj":"341","obj":"Gene:43740575"},{"id":"A342","pred":"tao:has_database_id","subj":"342","obj":"Tax:10090"},{"id":"A343","pred":"tao:has_database_id","subj":"343","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Other neutralizing human monoclonal Abs from transgenic mice were also reported. Ab 201 interfered with ACE2 binding by targeting S1 protein at the epitope aa 490–510. In contrast to 201, Ab 68 bound epitope aa 130–150 at the N-terminal of RBD but did not affect ACE2 binding [41]."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T65","span":{"begin":133,"end":140},"obj":"Body_part"}],"attributes":[{"id":"A65","pred":"fma_id","subj":"T65","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"Other neutralizing human monoclonal Abs from transgenic mice were also reported. Ab 201 interfered with ACE2 binding by targeting S1 protein at the epitope aa 490–510. In contrast to 201, Ab 68 bound epitope aa 130–150 at the N-terminal of RBD but did not affect ACE2 binding [41]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T172","span":{"begin":19,"end":24},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T173","span":{"begin":130,"end":132},"obj":"http://purl.obolibrary.org/obo/CLO_0050050"},{"id":"T174","span":{"begin":156,"end":158},"obj":"http://purl.obolibrary.org/obo/CLO_0001627"},{"id":"T175","span":{"begin":208,"end":210},"obj":"http://purl.obolibrary.org/obo/CLO_0001627"},{"id":"T176","span":{"begin":277,"end":279},"obj":"http://purl.obolibrary.org/obo/CLO_0053794"}],"text":"Other neutralizing human monoclonal Abs from transgenic mice were also reported. Ab 201 interfered with ACE2 binding by targeting S1 protein at the epitope aa 490–510. In contrast to 201, Ab 68 bound epitope aa 130–150 at the N-terminal of RBD but did not affect ACE2 binding [41]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T78","span":{"begin":133,"end":140},"obj":"Chemical"},{"id":"T79","span":{"begin":148,"end":155},"obj":"Chemical"},{"id":"T80","span":{"begin":200,"end":207},"obj":"Chemical"}],"attributes":[{"id":"A78","pred":"chebi_id","subj":"T78","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A79","pred":"chebi_id","subj":"T79","obj":"http://purl.obolibrary.org/obo/CHEBI_53000"},{"id":"A80","pred":"chebi_id","subj":"T80","obj":"http://purl.obolibrary.org/obo/CHEBI_53000"}],"text":"Other neutralizing human monoclonal Abs from transgenic mice were also reported. Ab 201 interfered with ACE2 binding by targeting S1 protein at the epitope aa 490–510. In contrast to 201, Ab 68 bound epitope aa 130–150 at the N-terminal of RBD but did not affect ACE2 binding [41]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T113","span":{"begin":0,"end":80},"obj":"Sentence"},{"id":"T114","span":{"begin":81,"end":167},"obj":"Sentence"},{"id":"T115","span":{"begin":168,"end":281},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Other neutralizing human monoclonal Abs from transgenic mice were also reported. Ab 201 interfered with ACE2 binding by targeting S1 protein at the epitope aa 490–510. In contrast to 201, Ab 68 bound epitope aa 130–150 at the N-terminal of RBD but did not affect ACE2 binding [41]."}

{"project":"2_test","denotations":[{"id":"32450171-15655773-66454467","span":{"begin":277,"end":279},"obj":"15655773"}],"text":"Other neutralizing human monoclonal Abs from transgenic mice were also reported. Ab 201 interfered with ACE2 binding by targeting S1 protein at the epitope aa 490–510. In contrast to 201, Ab 68 bound epitope aa 130–150 at the N-terminal of RBD but did not affect ACE2 binding [41]."}